Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
.
Show all posts
Showing posts with label
Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
.
Show all posts
Thursday, August 15, 2019
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
›
Imipenem ( Primaxin) Cilastatin Relebactam Merck (NYSE:MRK), known a...
›
Home
View web version
